You have 9 free searches left this month | for more free features.

City

Adelaide (1)

Melbourne (1)

Perth (1)

Richmond (1)

Tianjin (1)

Zhengzhou (1)

Condition

AML, Adult Recurrent (1)

Leukemia (1)

NHL (1)

NHL, Adult (1)

Overall Status

Recruiting (2)

Phase

phase 1 (2)

Sponsor

Shengke Pharmaceuticals (Jiangsu) Limited, China (1)

Shengke Pharmaceuticals Pty Ltd (1)

Collaborator

Intervention

eth-155008 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

eth-155008

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

Recruiting

NHL, Adult
AML, Adult Recurrent

ETH-155008

Zhengzhou, Henan, China
+1 more

Feb 24, 2023

NHL, Leukemia Trial in Australia (ETH-155008)

Recruiting

NHL
Leukemia

ETH-155008

Adelaide, South Australia, Australia
+4 more

Jun 8, 2022